BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC

This adverse event was reported 27 times

These drugs are most commonly taken by patients reporting BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC:

# Drug Count
0 PIOGLITAZONE 7
1 METFORMIN 5
2 METFORMIN ER 500 MG 5
3 METFORMIN ER 750 MG 5
4 GLIPIZIDE 3
5 SITAGLIPTIN 3
6 APIXABAN 2
7 ASPIRIN 2
8 ASPIRIN 325 MG 2
9 ASPIRIN 81 MG 2
See all common drugs associated with BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC

BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LAROTRECTINIB 1 0.0026
1 PIOGLITAZONE AND METFORMIN HYDROCHLORIDE 2 0.0016
2 AVELUMAB 2 0.0010
3 PIOGLITAZONE 7 0.0002
4 TOBRAMYCIN SULFATE 1 0.0001
5 STANDARDIZED SENNA CONCENTRATE 1 0.0001
6 CEFEPIME HYDROCHLORIDE 1 0.0001
7 DAPTOMYCIN 1 0.0001
8 AMANTADINE 1 0.0001
9 NINTEDANIB 1 0.0001
See all drugs enriched for association with BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC